ArticleScientific reports2025

Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction.

Alice Castaldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.